Antibody Technologies Market Research Reports & Industry Analysis
Antibody technologies involve the use of specialized proteins called antibodies to target and detect specific molecules, often used in medical diagnostics, therapeutics, and research. This field is evolving quickly due to scientific advancements and the growing demand for personalized treatments. To help you stay updated on the latest developments, MarketResearch.com offers a comprehensive collection of reports on antibody technologies.
Valuable Antibody Technologies Research and Analysis
- Find detailed data on various market segments including precision medicine, biosimilars, biologics, protein engineering, and more.
- Obtain antibody technologies market sizing and growth projections, discussions of key drivers and challenges, pricing and regulatory analysis, and company profiles.
- Read expert commentary on recent technological innovations and industry trends to gain a clear understanding of emerging opportunities.
Your Research Partner
Whether you're an experienced industry professional, a consultant, or a busy executive, our antibody technologies market research reports are designed to help you make informed decisions. With reliable data and thorough analyses, these reports support your decision-making process. By choosing MarketResearch.com, you can gain the intelligence needed to stay competitive and take advantage of new opportunities.
Antibody Technologies Industry Research & Market Reports
-
Global Antibody Drug Conjugates Market - 2023-2030
... 2030. The market is exhibiting at a CAGR of 16.6% during the forecast period (2023-2030). The global antibody drug conjugates market is driven by factors such as the increasing prevalence of cancer, growing investments in ... Read More
-
Global Monoclonal Antibody Therapeutics Market - 2023-2030
... The global monoclonal antibody therapeutics market is expected to exhibit a CAGR of 14.1% during the forecast period (2023-2030). Monoclonal antibody therapeutics (mAbs) are generated from identical antibodies (or simply antibody fragments) in a homogeneous ... Read More
-
Global Peripheral Blood Mononuclear Cells Market Assessment, By Product [Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, PBMC Isolation & Viability Kits], By Application [Immunology, Hematology, Vaccine Development, Toxicology, Infectious Disease, others], By Techniques [Density Gradient Centrifugation, Leukapheresis, Others], By Source [Human, Animal], By Region, Opportunities, and Forecast, 2016-2030F
... Gradient Centrifugation, Leukapheresis, Others], By Source [Human, Animal], By Region, Opportunities, and Forecast, 2016-2030F The Global Peripheral Blood Mononuclear Cells (PBMCs) Market is projected to reach USD 273.28 million by 2030 from USD 589.84 million ... Read More
-
Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents, Equipment, Kits), Application (Diagnostics (Cancer, Infectious, Autoimmune Diseases), Research, Forensic), End Users (Diagnostic laboratories, Research Institute) - Global Forecast to 2028
... reach USD 4.7 billion by 2028 from USD 3.2 billion in 2023, at a CAGR of 7.4% during the forecast period of 2023 to 2028. Market growth is largely driven by increased prevalence of cancer ... Read More
-
Global MMP13 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel MMP13 antibody drugs, increasing penetration rate of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in ... Read More
-
Global HDAC2 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel HDAC2 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in HDAC2 ... Read More
-
Global S100A11 Antibody Market Growth 2023-2029
... % from 2023 to 2029. The growing patient base, the launch of novel S100A11 antibody drugs, the increasing penetration rate of antibody drugs, and the continuous regulation of the entire biopharmaceutical industry are the key ... Read More
-
Global HMGB1 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel HMGB1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in revenue ... Read More
-
Global CD31 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel CD31 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in CD31 ... Read More
-
Global C-EBP Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel C/EBP antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the growth of C/EBP ... Read More
-
Global Anti-NeuN Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel anti-neuronal antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in revenue ... Read More
-
Global EEA1 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel EEA1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in revenue ... Read More
-
Global AQP4 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel AQP4 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in AQP4 ... Read More
-
Global HP1 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel HP1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in HP1 ... Read More
-
Immunohistochemistry Market Forecasts to 2028 – Global Analysis By Product (Kits, Antibody, Equipment and Reagents), Distribution channel (Research Applications, Diagnosis and Forensic) and End User and By Geography
... Market is accounted for $2.60 billion in 2022 and is expected to reach $4.24 billion by 2028 growing at a CAGR of 8.5% during the forecast period. Immunohistochemistry is critical for biomarker development. Immunohistochemistry is ... Read More
-
Global Anti Cyclic Citrullinated Peptide(Anti-CCP) Antibody Assay Kit Supply, Demand and Key Producers, 2023-2029
... a market growth of % CAGR during the forecast period (2023-2029). Anti Cyclic Citrullinated Peptide(Anti-CCP) Antibody Assay Kit is used to detect the presence of anti-cyclic citrulline polypeptide antibodies. Rheumatoid arthritis (RA) is a common ... Read More
-
Global Anti Cyclic Citrullinated Peptide(Anti-CCP) Antibody Assay Kit Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... Kit market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and ... Read More
-
Global ALPP Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of ALPP antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in ALPP antibody ... Read More
-
Global ACSL1 Antibody Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. Growing patient base, launch of novel ACSL1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the ... Read More
-
Global 53BP1 Antibody Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. Growing patient base, launch of novel 53BP1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the ... Read More
-
Global 4E-BP1 Antibody Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. Growing patient base, launch of novel 4E-BP1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the ... Read More
-
Global RAB27B Antibody Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. Growing patient base, launch of novel RAB27B antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the ... Read More
-
Global Bevacizumab Monoclonal Antibody Biosimilar Market Growth 2023-2029
... to grow at a CAGR of -15.0% from 2023 to 2029. United States market for Bevacizumab Monoclonal Antibody Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global CSN2 Antibody Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. Growing patient base, launch of new CSN2 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the ... Read More
-
Global PPT1 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of PPT1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in PPT1 antibody ... Read More
Research Assistance
